HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Winfield J. Wells Anjan S. Batra Colleen Sintek Vaughn A. Starnes Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wells, W. J. Articles by Starnes, V. A. Search for Related Content PubMed PubMed Citation Articles by Wells, W. J. Articles by Starnes, V. A. Related Collections Congenital - cyanotic

Ann Thorac Surg 2005;79:2072-2076
© 2005 The Society of Thoracic Surgeons

---

Original article: Cardiovascular

Obstruction in Modified Blalock Shunts: A Quantitative Analysis With Clinical Correlation

Childrens Hospital Los Angeles, Los Angeles, California

Accepted for publication December 28, 2004.

^_* Address reprint requests to Dr Wells, The Heart Institute at Childrens Hospital, LA, Division of Cardiothoracic Surgery, Mail Stop 66, 4650 Sunset Blvd, Los Angeles, CA90027 (E-mail: wwells{at}chla.usc.edu).

BACKGROUND: Despite numerous reports describing the clinical course of patients undergoing a modified Blalock-Taussig shunt (MBTS), there is limited information on shunt obstruction. No studies have quantified MBTS stenosis histopathologically and correlated that with demographic and clinical risk factors.

METHODS: From June 2001 to June 2003, 155 patients had MBTS takedown. The shunt operation (at median age 6 days; shunt size 3.5 mm in 56 [36%]; 4 mm in 84 [54%]; 5 mm in 15 [10%]) was performed on cardiopulmonary bypass (CPB) in 96 patients (62%). At elective takedown (at median 8.1 months), the shunt was excised and histopathologically analyzed for maximal narrowing. Demographics and clinical variables including age, weight, shunt size and duration, diagnosis, use of cardiopulmonary bypass, blood products, anastomosis sites, and concomitant antegrade flow were then tested for correlation with shunt stenosis.

RESULTS: The mean value for maximal narrowing of the shunt lumen was 34% ± 22%, and 32 patients (21%) had greater than 50% stenosis. Myofibroblastic proliferation, often associated with organized thrombus, caused the obstruction. Smaller shunt size (<4 mm) was a statistically significant risk factor for stenosis greater than 50% (odds ratio [OR] = 2.51; p = 0.028). Other variables that showed a clinically important association with obstruction but did not reach statistical significance included age less than 14 days at shunt (OR = 2.08, confidence interval [CI] 0.8 to 5.2), shunt on bypass (OR = 2.07, CI 0.9 to 4.8), and platelet use at shunt operation (OR = 1.96, CI 0.9 to 4.4).

CONCLUSIONS: Most MBTS develop stenosis by the time of takedown, and 21% have greater than 50% obstruction. Shunt size less than 4 mm is a risk factor for high-grade stenosis. Younger age, CPB, and use of platelets are other clinically important factors. Better conduits and suppression of intimal proliferation could potentially improve outcomes.

This article has been cited by other articles:

				V. Dirks, R. Pretre, W. Knirsch, E. R. Valsangiacomo Buechel, B. Seifert, M. Schweiger, M. Hubler, and H. Dave Modified Blalock Taussig shunt: a not-so-simple palliative procedure Eur J Cardiothorac Surg, March 28, 2013; (2013) ezt172v1. [Abstract] [Full Text] [PDF]

				T. M. Giglia, J. DiNardo, N. S. Ghanayem, R. Ichord, R. A. Niebler, K. C. Odegard, M. P. Massicotte, A. R. Yates, P. C. Laussen, and J. S. Tweddell Bleeding and Thrombotic Emergencies in Pediatric Cardiac Intensive Care: Unchecked Balances World Journal for Pediatric and Congenital Heart Surgery, October 1, 2012; 3(4): 470 - 491. [Abstract] [Full Text] [PDF]

				K.-J. Lee, A. Hinek, R. R. Chaturvedi, C. L. Almeida, O. Honjo, G. Koren, and L. N. Benson Rapamycin-Eluting Stents in the Arterial Duct: Experimental Observations in the Pig Model Circulation, April 21, 2009; 119(15): 2078 - 2085. [Abstract] [Full Text] [PDF]

				S. M. Bradley, C. C. Erdem, T.-Y. Hsia, A. M. Atz, V. Bandisode, and J. M. Ringewald Right Ventricle-to-Pulmonary Artery Shunt: Alternative Palliation in Infants With Inadequate Pulmonary Blood Flow Prior to Two-Ventricle Repair Ann. Thorac. Surg., July 1, 2008; 86(1): 183 - 188. [Abstract] [Full Text] [PDF]

				J. L Gibbs Ductal stenting for restricted pulmonary blood flow in neonates: 15 years on but still a very limited place in clinical practice Heart, July 1, 2008; 94(7): 834 - 835. [Full Text] [PDF]

				J. S. Tweddell Aspirin: A Treatment for the Headache of Shunt-Dependent Pulmonary Blood Flow and Parallel Circulation? Circulation, July 17, 2007; 116(3): 236 - 237. [Full Text] [PDF]

				J. S. Li, E. Yow, K. Y. Berezny, J. F. Rhodes, P. M. Bokesch, J. R. Charpie, G. A. Forbus, L. Mahony, L. Boshkov, V. Lambert, et al. Clinical Outcomes of Palliative Surgery Including a Systemic-to-Pulmonary Artery Shunt in Infants With Cyanotic Congenital Heart Disease: Does Aspirin Make a Difference? Circulation, July 17, 2007; 116(3): 293 - 297. [Abstract] [Full Text] [PDF]